April 5, 2018
11,683
321
184
4.32%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
4:16Now PlayingIn this Majority Report clip, we discuss a crazy new last passed by the House that allows experimental drugs to bypass the FDA.
We need your help to keep providing free videos! Support the Majority Report's video content by going to
Watch the Majority Report live MF at 12 p.m. EST at youtube.com/samseder or listen via daily podcast at
Download our FREE app
SUPPORT the show by becoming a member
LIKE us on Facebook
FOLLOW us on Twitter
SUBSCRIBE to us on YouTube
---House Republicans easily passed a controversial bill aimed at helping some dying patients get new access to experimental therapies Wednesday, resurrecting legislation that suffered a major setback just a week ago.
Passage of the bill, on a largely party-line vote of 267-149, is a step forward for the”right-to-try” movement, after House Republicans failed to pass the legislation last Tuesday. Then, they had hoped to rely on an easier, quicker process typically reserved for noncontroversial bills, which requires a two-thirds vote. That day, the bill actually got more support than Wednesday, with a vote of 259-140.
It’s not clear what’s next for the legislation, which has been a priority for President Trump and Vice President Mike Pence. The Senate unanimously passed a broader right-to-try bill last fall, but did so largely to satisfy the demands of the bill’s sponsor, Sen. Ron Johnson (R-Wis.) as he held up another priority law. A single senator could similarly choose to block or hold up consideration of the now House-passed bill. ---
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.